TAE226 Inhibits Human Neuroblastoma Cell Survival

REFERENCES

• Haas D., Ablin A. R., Miller C., Zoger S., Matthay K. K. Complete pathologic maturation and regression of stage IVS neuroblastoma without treatment. Cancer 1998; 62: 818–825
   Google Scholar
• Schaller M. D., Borgman C. A., Cobb B. S., Vines R. R., Reynolds A. B., Parsons J. T. pp125 fak a structurally distinctive protein-tyrosine kinase associated with focal adhesions. Proc. Natl. Acad. Sci. U.S.A. 1992; 89: 5192–5196
   PubMed Web of Science ®Google Scholar
• Hanks S. K., Polte T. R. Signaling through focal adhesion kinase. Bioessays 1997; 19: 137–145
   PubMed Web of Science ®Google Scholar
• Schlaepfer D. D., Hunter T. Integrin signaling and tyrosine phosphorylation: just the FAKs?. Trends Cell Biol. 1998; 8: 151–157
   PubMed Web of Science ®Google Scholar
• Frisch S. M., Vuori K., Ruoslahti E., Chan-Hui P. Y. Control of adhesion-dependent cell survival by focal adhesion kinase. J. Cell Biol. 1996; 134: 793–799
   PubMed Web of Science ®Google Scholar
• Owens L. V., Xu L., Craven R. J., Dent G. A., Weiner T. M., Kornberg L., Liu E. T., Cance W. G. Overexpression of the focal adhesion kinase (p125FAK) in invasive human tumors. Cancer Res. 1995; 55: 2752–2755
   PubMed Web of Science ®Google Scholar
• Owens L. V., Xu L., Dent G. A., Yang X., Sturge G. C., Craven R. J., Cance W. G. Focal adhesion kinase as a marker of invasive potential in differentiated human thyroid cancer. Ann. Surg. Oncol. 1996; 3: 100–105
   PubMed Web of Science ®Google Scholar
• Gutenberg A., Bruck W., Buchfelder M., Ludwig H. C. Expression of tyrosine kinases FAK and Pyk2 in 331 human astrocytomas. Acta Neuropathol. 2004; 108: 224–230
   PubMed Web of Science ®Google Scholar
• Hanks S. K., Ryzhova L., Shin N. Y., Brabek J. Focal adhesion kinase signaling activities and their implications in the control of cell survival and motility. Front. Biosci. 2003; 8: d982–996
   PubMed Web of Science ®Google Scholar
• Schlaepfer D. D., Mitra S. K. Multiple connections link FAK to cell motility and invasion. Curr. Opin. Genet. Dev. 2004; 14: 92–101
   PubMed Web of Science ®Google Scholar
• Sieg D. J., Hauck C. R., Schlaepfer D. D. Required role of focal adhesion kinase (FAK) for integrin-stimulated cell migration. J. Cell Sci. 1999; 112: 2677–2691
   PubMed Web of Science ®Google Scholar
• Frisch S. M., Screaton R. A. Anoikis mechanisms. Curr. Opin. Cell Biol. 2001; 13: 555–562
   PubMed Web of Science ®Google Scholar
• Frisch S. M. Evidence for a function of death-receptor-related, death-domain-containing proteins in anoikis. Curr. Biol. 1999; 9: 1047–1049
   PubMed Web of Science ®Google Scholar
• Xu L. H., Owens L. V., Sturge G. C., Yang X., Liu E. T., Craven R. J., Cance W. G. Attenuation of the expression of the focal adhesion kinase induces apoptosis in tumor cells. Cell Growth Differ. 1996; 7: 413–418
   PubMedGoogle Scholar
• Xu L. H., Yang X. H., Bradham C. A., Brenner D. A., Baldwin A. S., Craven R. J., Cance W. G. The focal adhesion kinase suppresses transformation-associated, anchorage-independent apoptosis in human breast cancer cells. J. Biol. Chem. 2000; 275: 30597–30604
   PubMed Web of Science ®Google Scholar
• Xu L. H., Yang X. H., Craven R. J., Cance W. G. The COOH-terminal domain of the focal adhesion kinase induces loss of adhesion and cell death in human tumor cells. Cell Growth Differ. 1998; 9: 999–1005
   PubMedGoogle Scholar
• Golubovskaya V. M., Gross S., Kaur A. S., Wilson R. I., Xu L. H., Yang X. H., Cance W. G. Simultaneous inhibition of focal adhesion kinase and SRC enhances detachment and apoptosis in colon cancer cell lines. Mol. Cancer Res. 2003; 1: 755–764
   PubMed Web of Science ®Google Scholar
• Shi Q., Hjelmeland A. B., Keir S. T., Song L., Wickman S., Jackson D., Ohmori O., Bigner D. D., Friedman H. S., Rich J. N. A novel low-molecular weight inhibitor of focal adhesion kinase, TAE226, inhibits glioma growth. Mol. Carcinog. 2007, Epub, PMID: 17219439
   PubMed Web of Science ®Google Scholar
• Hatakeyama S., Tomioka D., Kawahara E., Matsuura N., Masuya K., Miyake T., Umemura I, Kanazawa T., Honda T., Ohmori O. Anti-cancer activity of NVP-TAE226, a potent dual FAK/IGF-IR kinase inhibitor, against pancreatic cancer. J. Clin. Oncol. 2006; 18S: 13162
   Google Scholar
• Kawahara E., Ohmori O., Nonomura K., Murakami Y., Tomioka D., Niwa S, Meyer T., Mestan J., Honda T., Hatakeyama S. NVP-TAE226, a potent dual FAK/IGF-IR kinase inhibitor, prevents breast cancer metastasis in vivo. J. Clin. Oncol. 2006; 18S: 13163
   Google Scholar
• Lutz W., Stohr M., Schurmann J., Wenzel A., Lohr A., Schwab M. Conditional expression of N-myc in human neuroblastoma cells increases expression of alpha-prothymosin and ornithine decarboxylase and accelerates progression into S-phase early after mitogenic stimulation of quiescent cells. Oncogene 1996; 13: 803–812
   PubMed Web of Science ®Google Scholar
• Golubovskaya V., Finch R, Cance W. Direct interaction of the N-terminal domain of focal adhesion kinase with the N-terminal transactivation domain of p53. J. Biochem. Mol. Biol. 2005; 280: 25008–25021
   Google Scholar
• Kurenova E., Xu L. H., Yang X., Baldwin A. S., Craven R. J., Hanks S. K., Liu Z., Cance W. G. Focal adhesion kinase suppresses apoptosis by binding to the death domain of receptor-interacting protein. Molec. Cell Biol. 2004; 24: 4361–4371
   PubMed Web of Science ®Google Scholar
• Schaller M. D., Hildebrand J. D., Shannon J. D., Fox J. W., Vines R. R., Parsons J. T. Autophosphorylation of the focal adhesion kinase, pp125FAK, directs SH2-dependent binding of pp60src. Mol. Cell Biol. 1994; 14: 1680–1688
   PubMed Web of Science ®Google Scholar
• Schaller M. D., Parsons J. T. Focal adhesion kinase and associated proteins. Curr. Opin. Cell Biol. 1994; 6: 705–710
   PubMed Web of Science ®Google Scholar
• Xing A., Chen H. C., Nowlen J. K., Taylor S. J., Shalloway D., Guan J. L. Direct interaction of v-Src with the focal adhesion kinase mediated by the Src SH2 domain. Mol. Biol. Cell 1994; 5: 413–421
   PubMed Web of Science ®Google Scholar
• Calalb M. B., Polte T. R., Hanks S. K. Tyrosine phosphorylation of focal adhesion kinase at site in the catalytic domain regulates kinase activity: a role for Src family kinases. Mol. Cell Biol. 1995; 15: 954–963
   PubMed Web of Science ®Google Scholar
• Sonoda Y., Matsumoto Y., Funakoshi M., Yamamoto D., Hanks S. K., Kasahara T. Anti-apoptotic role of focal adhesion kinase (FAK). Induction of inhibitor of apoptosis proteins and apoptosis suppression by the overexpression of Fak in a human leukemic cell line, HL60. J. Biol. Chem. 2000; 275: 16309–16315
   Google Scholar
• Chen H. C., Guan J. L. Association of focal adhesion kinase with its potential substrate phosphatidylinositol 3-kinase. Proc. Natl. Acad. Sci. U.S.A. 1994; 91: 10148–10152
   PubMed Web of Science ®Google Scholar
• Wu Z. M., Yuan X. H., Jiang P. C., Li Z. Q., Wu T. Antisense oligonucleotides targeting the focal adhesion kinase inhibit proliferation, induce apoptosis and cooperate with cytotoxic drugs in human glioma cells. J. Neurooncol. 2006; 77: 117–123
   PubMed Web of Science ®Google Scholar
• Smith C. S., Golubovskaya V. M., Peck E., Xu L. H., Monia B. P., Yang X., Cance W. G. Effect of focal adhesion kinase (FAK) downregulation with FAK antisense oligonucleotides and 5-fluorouracil on the viability of melanoma cell lines. Melanoma Res. 2005; 15: 352–362
   Google Scholar
• Satoh T. H., Surmacz T. A., Nyormoi O., Whitacre C. M. Inhibition of focal adhesion kinase by antisense oligonucleotides enhances the sensitivity of breast cancer cells to camptothecins. Biocell. 2003; 27: 47–55
   PubMed Web of Science ®Google Scholar
• Hauck C. R., Sieg D. J., Hsia D. A., Loftus J. C., Gaarde W. A., Monia B. P., Schlaepfer D. D. Inhibition of focal adhesion kinase expression or activity disrupts epidermal growth factor-stimulated signaling promoting the migration of invasive human carcinoma cells. Cancer Res. 2001; 61: 7079–7090
   PubMed Web of Science ®Google Scholar
• Earley S., Plopper G. E. Disruption of focal adhesion kinase slows transendothelial migration of AU-565 breast cancer cells. Biochem. Biophys. Res. Comm. 2006; 350: 405–412
   PubMed Web of Science ®Google Scholar
• Van Nimwegen M. J., Huigsloot M., Camier A., Tijdens I. B., van de Water B. Focal adhesion kinase and protein kinase B cooperate to suppress doxorubicin-induced apoptosis of breast tumor cells. Mol. Pharmacol. 2006; 70: 1330–1339
   PubMed Web of Science ®Google Scholar
• Mitra S. K., Lim S. T., Chi A., Schlaepfer D. D. Intrinsic focal adhesion kinase activity controls orthotopic breast carcinoma metastasis via the regulation of urokinase plasminogen activator expression in a syngeneic tumor model. Oncogene 2006; 25: 4429–4440
   PubMed Web of Science ®Google Scholar
• Park H. B., Golubovskaya V., Xu L., Yang X., Lee L. W., Scully S., Craven R. J., Cance W. G. Activated Src increases adhesion, survival, and alpha2-integrin expression in human breast cancer cells. Biochem. J. 2004; 378: 559–567
   PubMed Web of Science ®Google Scholar
• Halder Halder J., Kamat A. A., Landen C. N., Han L. Y., Lutgendorf S. K., Lin Y. G., Merritt W. M., Jennings N. B., Chavez-Reyes A., Coleman R. L., Gershenson D. M., Schmandt R., Cole S. W., Lopez-Berestein G., Sood A. K. Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy. Clin. Cancer Res. 2006; 12: 4916–4924
   PubMed Web of Science ®Google Scholar
• Lipinski C. A., Tran N. L., Menashi E., Rohl C., Kloss J., Bay C., Berens M. E., Loftus J. C. The tyrosine kinase Pyk2 promotes migration and invasion of glioma cells. Neoplasia 2005; 5: 435–445
   Google Scholar
• Duxbury M. S., Ito H., Benoit E., Zinner M. J., Ashley S. W., Whang E. E. RNA interference targeting focal adhesion kinase enhances pancreatic adenocarcinoma gemcitabine chemosensitivity. Biochem. Biophys. Res. Comm. 2003; 311: 786–792
   PubMed Web of Science ®Google Scholar